Recently approved drug by FDA for treatment of Lennox-Gestaut syndrome:
High-Yield Explanation
Answer- D. RufinamideRecently approved drug by FDAfor treatment of Lennox-Gestaul syndrome is rufinamide.Rufinamide:Rufinamide was approved by the US Food and Drug Administration on November 14, 2008 as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.